Epigenetic regulation of key vascular genes and growth factors
The DOI matches its Crossref record; 71 of the 72 references it cites were found in a registry or an index.
Abstract
The role of small RNAs in epigenetic regulation is an emerging field. This research may also open novel treatment strategies based on manipulation of the epigenetic status of the target tissues. Our objective is to review epigenetic regulation of key vascular genes and growth factors. Vascular endothelial growth factor A (VEGF-A) is one of the key players in regulating and maintaining cardiovascular functions and pathology. Although its epigenetic regulation is still not completely understood, expression of the VEGF gene can be manipulated by epigenetic mechanisms using small RNAs that are targeted to the gene promoter which results in the alteration of histone code. VEGF exerts its effects mostly through two receptors, VEGFR1 and VEGFR2, and their expression is also regulated by promoter DNA methylation in various cancer cells. These findings suggest the importance of epigenetic mechanisms in the regulation of vascular functions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
1 retracted
Kang, S. K., Kang, K., Jee, M. K., & Kim, B. S. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2010.0010 · Cited by 6 · cited 2×
“Upon treatment with VEGF-A, methylation patterns in promoters of both genes were diminished in endothelial progenitor cells.(36) VEGF-A expression can therefore lead to epigenetic modifications in promoters of other genes.”
BackgroundRetractedChromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756 · cited 1×
“chromatin-associated proteins and translated into a transcriptionally active or repressed genetic state.(6,7) This histone code interacts with proteins and has varying effects on chromatin structure and gene accessibility.”
BackgroundCrystal structure of the nucleosome core particle at 2.8 Å resolution
Luger, K., Mäder, A. W., Richmond, R. K., Sargent, D. F., & Richmond, T. J. (1997) · Nature · doi:10.1038/38444 · Cited by 9,466 · cited 1×
“around which 145–147 bp of DNA is wrapped around twice forming the nucleosome core.(4,5) Histones are targets of posttranslational modifications, which include methylation, acetylation,”
BackgroundHistone demethylation mediated by the nuclear amine oxidase homolog LSD1
Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A., Casero, R. A., & Shi, Y. (2004) · Cell · doi:10.1016/j.cell.2004.12.012 · Cited by 4,051 · cited 2×
“Examples of demethylating proteins are the family of Jarid1 of JmjC proteins and the nuclear amine oxidase homologue lysine-specific demethylase 1 (LSD1).(21,22) The mono-, di-, and trimethylation layer of modifications complicates the action of enzymes further.”
BackgroundHeterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628 · cited 1×
“Mice with only one VEGF-A allele do not develop proper vascular network and die early in embryogenesis.(27) On the other hand, only two-fold excess of VEGF-A results in embryogenic lethality.”
BackgroundLong Noncoding RNA as Modular Scaffold of Histone Modification Complexes
Tsai, M.-C., Manor, O., Wan, Y., Mosammaparast, N., Wang, J. K., Lan, F., Shi, Y., Segal, E., & Chang, H. Y. (2010) · Science · doi:10.1126/science.1192002 · Cited by 3,290 · cited 1×
“directing a specific combination of histone methylations to the target gene chromatin.(61) The report suggests a possibility that other lincRNAs could also guide distinct histone modification patterns to”
BackgroundThe Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., & Nakatani, Y. (1996) · Cell · doi:10.1016/s0092-8674(00)82001-2 · Cited by 2,952 · cited 1×
“complex of NCoR and Sin3), which is strongly correlated with the fact that acetylation of histone residues mark active genes.(16,17) HMTs seem to be the most specific of the histonemodifying enzymes, such as SUV39H1, which only methylates H3K9.”
BackgroundRegulation of chromatin structure by site-specific histone H3 methyltransferases
Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B. D., Sun, Z.-W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C. P., Allis, C. D., et al. (2000) · Nature · doi:10.1038/35020506 · Cited by 2,845 · cited 2×
“Many coactivators contain the HAT activity (e.g. p300/CBP), whereas some global transcriptional repressors are associated with HDACs (e.g. complex of NCoR and Sin3), which is strongly correlated with the fact that acetylation of histone residues mark active genes.16,17 HMTs seem to be the most specific of the histonem…”
BackgroundEpigenetics: A landscape takes shape
Goldberg, A. D., Allis, C. D., & Bernstein, E. (2007) · Cell · doi:10.1016/j.cell.2007.02.006 · Cited by 2,466
Research works printed but not linked: 2
- Veikkola, 2000, Cancer Research, 60, 203
- Slater, 2005, Journal of experimental & clinical cancer research : CR, 24, 463
Cited by
Transition from inflammation to proliferation: a critical step during wound healing
Landén, N. X., Li, D., & Ståhle, M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2268-0 · Cited by 1,980
Flow-dependent epigenetic DNA methylation regulates endothelial gene expression and atherosclerosis
Dunn, J., Qiu, H., Kim, S., Jjingo, D., Hoffman, R., Kim, C. W., Jang, I., Son, D. J., Kim, D., Pan, C., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74792 · Cited by 307
“Recently, DNA methylation has been implicated as a novel risk factor for atherosclerosis in smooth muscle cells (39–43).”
Advances in targeting histone deacetylase for treatment of solid tumors
Shi, M.-Q., Xu, Y., Fu, X., Pan, D.-S., Lu, X.-P., Xiao, Y., & Jiang, Y.-Z. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01551-8 · Cited by 161
“Histones undergo dynamic modifications through the action of specific enzymes [27].”
BackgroundAlternation of histone and DNA methylation in human atherosclerotic carotid plaques
Napieralski, R., Wagner, E., Gebhard, H., Schmitt, M., Zimmermann, A., Eckstein, H.-H., Greißel, A., Culmes, M., Zernecke, A., & Pelisek, J. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-10-0852 · Cited by 82
“Both, an increased methylation of H3K4 as well as a reduction in methylation of H3K9 facilitate gene expression (3, 14).”
BackgroundRegulation and involvement of matrix metalloproteinases in vascular diseases
Sen, U. (2015) · Frontiers in bioscience · doi:10.2741/4378 · Cited by 87
“MMP-9 has also been shown to be regulated epigenetically (161).”
Background
Metadata
- Authors
- Turunen, M. P., & Yla-Herttuala, S.
- ORCID
- Turunen, M. P.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-04-14
- Volume
- 90
- Issue
- 3
- Pages
- 441-446
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W1994145649
- Cited by
- 41
- References
- 72
- Citations by year
- 2026: 2 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 5 · 2020: 2 · 2019: 3 · 2018: 4 · 2017: 2 · 2016: 5 · 2015: 6 · 2014: 3 · 2013: 1 · 2012: 1
- FWCI
- 0.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cardiovascular Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- epigenetic regulation, growth factors, VEGF-A, VEGFR1, VEGFR2, small RNA, DNA methylation, histone modifications, promoter regulation, vascular function, cancer cells
- MeSH terms
- Animals, Blood Vessels, Cardiovascular Diseases, Humans, Matrix Metalloproteinases, RNA, Small Interfering, Vascular Endothelial Growth Factor A, Angiogenic Proteins, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epigenetic regulation of key vascular genes and growth factors. https://app.cochat.ai/papers/10.1093/cvr/cvr109
- The paper
- Turunen, M. P., & Yla-Herttuala, S. (2011). Epigenetic regulation of key vascular genes and growth factors. Cardiovascular Research. https://doi.org/10.1093/cvr/cvr109
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.